Medicare Enrolled

Dr. Chithranjan Nath, MD

Endocrinology · Fishkill, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
400 WESTAGE BUSINESS CTR DR STE 205, Fishkill, NY 12524
8458960008
In practice since 2007 (19 years)
NPI: 1053456855 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nath? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nath

Dr. Chithranjan Nath is an endocrinology specialist in Fishkill, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Nath performed 2,520 Medicare services across 1,465 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nath received a total of $269,863 from 34 pharmaceutical and/or device companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nath is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 24% volume in NY $269,863 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,520
Medicare services
Top 24% in NY for endocrinology
1,465
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~133 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
616 $95 $337
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
259 $16 $42
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
258 $9 $23
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
242 $8 $21
Liver function blood test panel 242 $8 $20
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
237 $9 $24
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
208 $8 $12
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
208 $13 $33
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
83 $148 $474
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $66 $236
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
36 $132 $437
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
29 $5 $14
New patient office visit, complex (60-74 min) 20 $173 $582
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
17 $5 $13
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
13 $69 $311
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$269,863
Total received (2018-2024)
Avg $38,552/year across 7 years
Top 3% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
632
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$263,955 (97.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,831 (1.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,077 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,845
2023
$2,929
2022
$8,034
2021
$47,305
2020
$41,396
2019
$65,616
2018
$99,737

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,269
ROCHE DIABETES CARE, INC.
$777
Novo Nordisk Inc
$183
Lilly USA, LLC
$152
Amgen Inc.
$78
Novartis Pharmaceuticals Corporation
$72
Bayer Healthcare Pharmaceuticals Inc.
$54
Abbott Laboratories
$35
Medtronic, Inc.
$33
Janssen Biotech, Inc.
$32
Amneal Pharmaceuticals LLC
$29
Dexcom, Inc.
$25
Ultragenyx Pharmaceutical Inc.
$25
IBSA Pharma Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Insulet Corporation
$18
AstraZeneca Pharmaceuticals LP
$16
Top 3 companies account for 87.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$75,326
AstraZeneca Pharmaceuticals LP
$61,640
SANOFI-AVENTIS U.S. LLC
$56,375
AbbVie, Inc.
$24,414
Merck Sharp & Dohme Corporation
$16,423
Boehringer Ingelheim Pharmaceuticals, Inc.
$12,613
AbbVie Inc.
$10,401
ABBVIE INC.
$7,007
Lilly USA, LLC
$1,150
IBSA Pharma Inc.
$1,058
ROCHE DIABETES CARE, INC.
$777
Sentynl Therapeutics, Inc.
$400
Amneal Pharmaceuticals LLC
$363
Abbott Laboratories
$306
Corcept Therapeutics
$294
Amarin Pharma Inc.
$231
Radius Health, Inc.
$189
Janssen Pharmaceuticals, Inc
$130
Amgen Inc.
$104
Medtronic MiniMed, Inc.
$102
Novartis Pharmaceuticals Corporation
$96
Bayer Healthcare Pharmaceuticals Inc.
$70
Insulet Corporation
$58
Medtronic, Inc.
$57
Gemini Laboratories, LLC
$46
Antares Pharma, Inc.
$34
Janssen Biotech, Inc.
$32
RECORDATI_RARE_DISEASES_INC.
$31
Dexcom, Inc.
$25
Ultragenyx Pharmaceutical Inc.
$25
SANOFI PASTEUR INC.
$23
MannKind Corporation
$22
Horizon Therapeutics plc
$21
Xeris Pharmaceuticals, Inc.
$20
Top 3 companies account for 71.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Accu-Chek Guide · Androgel · BYDUREON · Crysvita · Dexcom G6 Transmitter · EVENITY · Enbrel · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · Guardian Connect · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · MINIMED 780G · MOUNJARO · Minimed 670G System · NOCDURNA · Omnipod · Ozempic · RECORLEV · RYBELSUS · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNTHROID · Saxenda · Synthroid · TAVNEOS · TEPEZZA · TOUJEO · TREMFYA · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for endocrinology in NY.

Looking for an endocrinology specialist in Fishkill?
Compare endocrinologists in the Fishkill area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
40
Per 100K population
13.5
County median income
$97,273
Nearest hospital
MONTEFIORE ST LUKE'S CORNWALL
8.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nath is a clinical cardiology specialist, with above-average Medicare volume (top 24% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nath experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nath performed 616 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nath receive payments from pharmaceutical companies?
Yes. Dr. Nath received a total of $269,863 from 34 companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nath's costs compare to other endocrinologists in Fishkill?
Dr. Nath's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →